Market cap
₹0 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
-2 %
-
ROCE
-2 %
-
Industry P/E
39.9
-
EV/EBITDA
9.3
-
Debt to Equity
0
-
Book Value
₹--
-
EPS
₹-0.1
-
Face value
10
-
Shares outstanding
4,124,650
10 Years Aggregate
CFO
₹-1.07 Cr
EBITDA
₹-0.73 Cr
Net Profit
₹-0.61 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vardhaman Laboratories
| -- | 3.3 | -- | -- | -- | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2015
|
|---|---|
|
Vardhaman Laboratories
| -40.6 |
|
BSE Sensex
| -5.0 |
|
BSE Healthcare
| 15.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vardhaman Laboratories
|
0.5 | 0.2 | 0.0 | 0.0 | -- | -1.2 | -- | 0.1 |
| 3,281.6 | 26,870.9 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.6 | 15.5 | |
| 813.5 | 16,000.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 449.9 | 17,241.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.7 | 20,739.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,532.2 | 17,579.4 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,103.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 29,891.8 | 1,935.8 | 288.2 | 20.6 | 29.8 | 103.7 | 22.3 | |
| 403.4 | 16,284.0 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,103.6 | 3,564.0 | 414.0 | 15.3 | 8.4 | 78.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Vardhaman Laboratories
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1985
-
Chairman
Dharamchand Shah
-
Managing Director
--
-
Headquarters
Sangli, Maharashtra
-
Website
--
FAQs for Vardhaman Laboratories
What is the current share price of Vardhaman Laboratories Ltd Today?
The share price of Vardhaman Laboratories Ltd is ₹0.51 (BSE) as of 16-Aug-2019 IST. Vardhaman Laboratories Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Vardhaman Laboratories Ltd?
Since, TTM earnings of Vardhaman Laboratories Ltd is negative, P/E ratio is not available.
The P/B ratio of Vardhaman Laboratories Ltd is 0.11 times as on 16-Aug-2019, a 97 discount to its peers’ median range of 4.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2018 |
0.00 |
0.14 |
2017 |
0.00 |
0.14 |
2016 |
0.00 |
0.23 |
2015 |
0.00 |
0.28 |
2014 |
0.00 |
0.00 |
What is the 52 Week High and Low of Vardhaman Laboratories Ltd?
The 52-week high and low of Vardhaman Laboratories Ltd are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of Vardhaman Laboratories Ltd?
Vardhaman Laboratories Ltd has a market capitalisation of ₹ 0 Cr as on 16-Aug-2019. As per SEBI classification, it is a company.
Should I invest in Vardhaman Laboratories Ltd?
Before investing in Vardhaman Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.